Ocuphire Pharma, Inc. Annual report pursuant to Section 13 and 15(d)

Warrants (Summary Of Changes In Warrants Outstanding During The Period) (Details) (USD $)	0 Months Ended			12 Months Ended
	Jan. 21, 2014	Oct. 16, 2013	Jul. 26, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Warrants [Abstract]
Number of warrants, Outstanding				24,968,868	21,656,142
Weigted average exercise price, Outstanding				$ 1.07invest_InvestmentWarrantsExercisePrice	$ 0.86invest_InvestmentWarrantsExercisePrice	$ 0.89invest_InvestmentWarrantsExercisePrice
Number of warrants, Issued	4,761,905rnn_InvestmentWarrantsIssuedNumber	3,567,309rnn_InvestmentWarrantsIssuedNumber	3,990,000rnn_InvestmentWarrantsIssuedNumber	4,761,905rnn_InvestmentWarrantsIssuedNumber	8,421,001rnn_InvestmentWarrantsIssuedNumber
Weighted average exercise price, Issued				$ 1.28	$ 0.59
Number of warrants, Exercised				(12,058,871)rnn_InvestmentWarrantsExercisedNumber	(4,681,497)rnn_InvestmentWarrantsExercisedNumber
Weighted average exercise price, Exercised				$ 0.52	$ 0.47
Number of warrants, Expired				(4,466,031)rnn_InvestmentWarrantsExpiredNumber	(426,778)rnn_InvestmentWarrantsExpiredNumber
Weighted average exercise price, Expired				$ 1.59	$ 1.67
Number of warrants, Outstanding				13,205,871	24,968,868	21,656,142
Weigted average exercise price, Outstanding				$ 1.07invest_InvestmentWarrantsExercisePrice	$ 0.86invest_InvestmentWarrantsExercisePrice	$ 0.89invest_InvestmentWarrantsExercisePrice